The popularity of minimally invasive techniques for the treatment of symptomatic uterine fibroids as an alternative to surgical procedures is increasing. The most widely used procedure of this type is uterine artery embolisation (UAE). During UAE embolic material is administered into bilateral uterine arteries to reduce the tumour's blood supply. This results in necrosis, fibroid volume reduction and relief of symptoms. In some cases tumour regrowth and recurrence of clinical symptoms after UAE are observed, due to fibroid revascularisation. In this study uterine fibroid vascularisation changes after UAE were analysed during a 3 months follow-up period. Methods: 64 premenopausal patients with symptomatic intramural fibroids qualified for UAE in the 3rd Chair and Department of Gynecology, Medical University of Lublin, were included in the study. Dominant fibroid vascularisation was evaluated before UAE, 24 hours and 3 months after UAE using the VOCAL technique by calculating the vascular-flow index (VFI). Data were analysed using the repeated measures ANOVA with the post hoc Fisher's test. P values below 0,05 were considered significant. Results: Mean fibroid VFI before UAE was estimated at 0,85 (±0,11 SE), 24 hours after UAE at 0,03 (±0,01 SE), and after 3 months at 0,08 (±0,02 SE). Analysis of variance showed a significant (p <0.0001) effect of time after UAE on the vascularisation of uterine fibroids. A post hoc analysis showed that the fibroid VFI's assessed after 24 hours and 3 months after UAE were significantly lower than before UAE (p <0,0001). Fibroid VFI assessed 24 hours after UAE was not significantly different from VFI 3 months after UAE (p = 0.62). Conclusions: Statistically significant fibroid vascular-flow index reduction was observed at 24 hours after UAE. Three months after UAE this effect was maintained, with an insignificant increase of VFI between 24 hours and 3 months post UAE.
Objectives: To evaluate the accuracy of transvaginal ultrasonography to discriminate endometrial cancerous pathology from benign lesions based on IETA and MUSA rules and definitions. Methods: We analysed retrospectively ultrasonic images (2D, 3D/4D) of 240 women that attained the department of gynecological ultrasound complaining for sudden appearance of ''vaginal bleeding''. They underwent transvaginal ultrasonography and treated by D&C. Based on histological diagnosis, data have been allocated into 2 groups of benign and malignant cases irrespectively of hormonal status of women (pre-or postmenopausal).
Results: All cancerous cases have been correctly diagnosed via application of IETA criteria (100%). In 22 women (15%), endometrial neoplasia has been initially recorded via ultrasonography. Cervical cancer that coexisted in 4 cases obscured the clear delineation between endometrial cavity and cervical canal. Intramural and submucous myomas, described via ultrasonography as well defined lesions, destroyed the endometrial entity producing complex structures that presented differentiated echogenicity (55%). Pathology of adenomyosis has been underlined via hysterectomy in 7 of 18 myomatous uteri. Endometrial polypoid hyperplasia (with or without atypia) has been diagnosed in the rest of patients (n=6/22). Increased vascularisation has been observed in these overdiagnosed as cancerous 22 cases. Conclusions: Application of IETA criteria represents an accurate method to investigate via ultrasonography the possibility of underlying endometrial malignancy in symptomatic women (pre and postmenopausal). False positive results obliged 15% of our sample to undergo a minimal surgical procedure. But none of the cancerous patients has been lost as ''benign case''. More prospective studies should be organised in order gynecologists that perform transvaginal ultrasonography to be trained and to become familiar regarding the vascularisation endometrial pattern in benign pathologies such as hyperplasia, adenomyosis and polyps.
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Inter-and intrarater reproducibility in detecting deep myometrial invasion and cervical stromal invasion using 2D-TVU and 3D-VCI Objectives: The purpose of this work was to assess the existence of a connection between the atypical glandular cells (AGC) on cervical smears and gynecological changes on ultrasound. Methods: A random sample of 60 women with AGC was selected between 143 cases detected in a tertiary care hospital between 2012 and 2016. Pelvic ultrasounds were analysed to determine whether there were any changes. Results: Of the 58 women, 13 were excluded due to insufficient information and 1 awaits investigation. A total of 44 cases was considered. The mean age was 50,7+/-13,0 years old (31-88), the majority of women was Caucasian (84,1%), and 75,0% had vaginal deliveries. 40,9% was menopausal at the time of smear collection.
On the ultrasound evaluation, 7 women (15,9%) had an endometrial thickening, suspect of malignancy, and in 5 of these (11,4%) endometrial adenocarcinoma was confirmed in the hystological analysis, having been treated accordingly.
As far as benign pathology was concerned, the most common finding was adenomyosis, present in 75,0% of women (n=33), including 3 of the ones with malignancy. Some of these women had other myometrial findings, such as fibromyomas, but the majority (63,6% n=21) only had adenomyosis. Some women had other ultrasound features apart from adenomyosis, which varied from small benign ovarian cysts to endocervical cysts, endometrial polyps and other findings.
Most women repeated the cervical smear and had normal results on follow-up. Conclusions: Since some women with AGC have malignant pathology, it is of the utmost importance to investigate the cervix, endometrium and adnexa thoroughly. Fortunately, the majority of women with AGC only has benign pathology, such as adenomyosis. After discarding malignancy, adenomyosis seems to be the most consistent change throughout the sample.
Since these findings are based on a small sample, further studies are warranted in order to better determine whether there are any consistent sonographic changes associated with AGC.
